Lifestyle
- Regular exercise
- Adequate hydration
- Avoid smoking
Red Blood Cells · RBC · Rote Blutkörperchen
The RBC test quantifies the number of red blood cells in a given volume of blood, reflecting the body's capacity for oxygen transport.
Reference ranges may vary based on altitude and smoking status.
Erythrozyten, commonly known as red blood cells (RBCs), are a crucial component of the blood responsible for transporting oxygen from the lungs to tissues and carbon dioxide from tissues back to the lungs. RBCs are characterized by their biconcave shape, which increases their surface area for gas exchange. Researchers have found that RBC count, size, and morphology can provide significant insights into various hematological conditions. Clinically, RBC levels are vital in diagnosing and monitoring anemia, polycythemia, and hemolytic disorders. Abnormal RBC morphology can indicate specific types of anemia, such as microcytic, normocytic, or macrocytic anemia, guiding further diagnostic testing and treatment strategies. For athletes and biohackers, maintaining optimal RBC levels is essential for maximizing oxygen delivery and endurance performance. Elevated RBC counts can enhance athletic performance by improving oxygen transport, but excessive levels may increase the risk of thrombosis. Conversely, low RBC counts can impair performance and recovery. Researchers observed that RBC levels can be influenced by factors such as altitude, hydration status, and certain medications. It is important to consider these variables when interpreting RBC measurements to avoid misdiagnosis or unnecessary interventions.
Klinische Bedeutung
Elevated RBC levels may indicate polycythemia vera or chronic hypoxia, while reduced levels often suggest anemia or bone marrow suppression. Abnormal RBC morphology can further specify the type of anemia present.
Progressively rising RBC values may suggest polycythemia or chronic hypoxia. Re-test if levels exceed the upper reference range.
Progressively falling RBC values may indicate developing anemia or bone marrow suppression.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult physician before supplementing iron, especially if not iron deficient.
RBC counts can vary slightly throughout the day; morning samples are preferred.
Testing Frequency
Annually for healthy adults, more frequently if symptomatic or under treatment.
May affect
Current research suggests that reference ranges for red blood cell (RBC) parameters, such as red cell mass measurement, remain debated due to variability in plasma volume effects and diagnostic accuracy. Researchers have not yet established optimal targets for distinguishing between different types of anemia based on RBC morphology. Additionally, clinical questions regarding the long-term outcomes of treatments for autoimmune hemolytic anemia and the role of emerging biomarkers in diagnosing congenital hemolytic anemias remain unanswered.
1,193
Total Citations
19
Human/RCT
6.6
Avg. Influence
2026
Latest
This study focused on autoimmune hemolytic anemia (AIHA), a serious condition characterized by the destruction of red blood cells by the immune system. Researchers observed that diagnosis relies on clinical signs and a positive direct antiglobulin test. Treatment options vary based on the type of antibodies involved and may include corticosteroids and immunosuppressive drugs.
This study examined red blood cell (RBC) morphology as a diagnostic tool in patients with anemia. Researchers found that abnormalities in RBC shape and features can provide critical insights for differential diagnosis, particularly in various types of anemia. Proper interpretation of RBC morphology can guide laboratory follow-up and the selection of definitive diagnostic tests.
Researchers investigated the relationship between red blood cell dysfunction and diabetes mellitus. The study found that chronic hyperglycemia leads to significant morphological and functional changes in RBCs, contributing to anemia and increased morbidity in diabetic patients. The findings highlight the complex interplay between RBC alterations and diabetes-related complications.
Researchers analyzed changes in routine laboratory tests in COVID-19 patients, focusing on red blood cell counts. They found that RBC and hemoglobin levels were significantly lower in ICU patients compared to non-ICU patients, indicating potential diagnostic and prognostic implications for disease severity.
This study focused on red blood cell (RBC) aggregation and its impact on blood flow dynamics. Researchers observed that RBC aggregability varies significantly and can be influenced by factors such as age and treatment. Understanding these variations is important for both basic science and clinical applications.
This study reviewed technologies for measuring red blood cell deformability, which is crucial for oxygen delivery in the body. Researchers found that advancements in microfluidics have improved the sensitivity and throughput of these measurements compared to traditional methods. The study discussed potential applications for assessing RBC deformability in various diseases.
Researchers investigated congenital hemolytic anemia, which involves the destruction of red blood cells due to intrinsic or extrinsic factors. The study found that typical symptoms include pallor, jaundice, and splenomegaly, with laboratory features showing anemia and hyperbilirubinemia. Some cases may be curable with splenectomy, while others require supportive care.
This review addressed the challenges in discovering red blood cell (RBC) biomarkers through proteomics. Researchers found that the unique characteristics of mature RBCs complicate the identification of functional proteins, which is essential for understanding various anemias and RBC-related disorders.
Researchers discussed the potential of manufactured red blood cells (RBCs) as a treatment for inherited anemias. They found that laboratory-grown RBCs could address compatibility issues in transfusions, with successful proof-of-principle mini-transfusions conducted. Ongoing trials aim to assess the equivalence of manufactured RBCs to natural donor RBCs.
Researchers found that red blood cell metabolism plays a significant role in hemolysis during aging and storage. The study identified genetic factors linked to RBC recovery after transfusion and highlighted the association of specific gene variants with hemolysis in blood donors. These findings may inform future blood transfusion practices.
Research publications about Erythrozyten over time
7totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer